激素对抗期前列腺癌的诊断与治疗(12例报告)
Diagnosis and therapy of hormone refractory stage prostate cancer(report of 12 case)
出处
《福建医科大学学报》
2003年第1期99-100,共2页
Journal of Fujian Medical University
参考文献6
-
1[1]Isaacs JT. The biology of hormone refractory prostate cancer. Why does it develop[J]? Urol Clin North Am, 1999,26(2):263-273.
-
2[2]Joyce R,Fenton MA,Rode P,et al. High dose bicalutamide for androgen independent prostate cancer: effect of prior hormonal therapy[J]. J Urol, 1998,159(1):149-153.
-
3[3]Isaacs JT,Coffey DS. Adaptation versus selection as the mechanism responsible for the relapse of prostatic cancer to androgen ablation therapy as studied in the Dunning R-3327-H adenocarcinoma[J]. Cancer Res, 1981,41(12 Pt1):5070-5075.
-
4[4]Horoszewicz JS,Leong SS,Kawinski E,et al. LNCaP model of human prostatic carcinoma[J]. Cancer Res, 1983,43(4):1809-1818.
-
5[5]Scher HI,Zhang ZF,Nanus D,et al. Hormone and antihormone withdrawal: implications for the management of androgen-independent prostate cancer[J]. Urology, 1996,47(1A Suppl):61-69.
-
6[6]Byrne RL,Horne CH,Robinson MC,et al. The expression of waf-1,p53 and bcl-2 in prostatic adenocarcinoma[J]. Br J Urol, 1997,79(2):190-195.
-
1景中民(综述),李晓强(审校).雄激素非依赖性前列腺癌发生的相关分子机制研究进展[J].国际泌尿系统杂志,2010,30(6):766-770.
-
2杨堃,江鱼.激素对抗期前列腺癌(HRPC)的最新治疗选择[J].国外医学(泌尿系统分册),2000,20(4):145-147. 被引量:1
-
3金鹏(综述),彭佑共(综述),杨罗艳(审校).雄激素非依赖性前列腺癌的治疗进展[J].国际泌尿系统杂志,2007,27(6):757-763. 被引量:1
-
4汪涌,邵晨.前列腺癌雄激素非依赖性相关研究的进展[J].国际泌尿系统杂志,2004,0(S1):9-14. 被引量:1
-
5孙秀,李海平.雄激素水平与女性乳腺癌关系研究进展[J].河北医科大学学报,2009,30(7):750-753. 被引量:1
-
6蔡伟忠,郑松,许恩赐,李启镛,岑和,陈仕平.激素对抗期前列腺癌的诊断与治疗(附12例报告)[J].齐齐哈尔医学院学报,2003,24(8):879-880.
-
7温星桥,高新.激素非依赖性前列腺癌的分型治疗进展[J].国际泌尿系统杂志,2006,26(2):182-185.
-
8方晓亮(综述),康健(审校),齐隽(审校).雄激素非依赖性前列腺癌和雄激素受体的研究进展[J].国际泌尿系统杂志,2009,29(4):500-505.
-
9闫天中,靳风烁,江军,李彦锋,李黔生.良性前列腺增生与前列腺癌的VEGF、IL-6表达[J].医学临床研究,2004,21(7):762-764. 被引量:2
-
10陈诚,黄群联.去势抵抗性前列腺癌的临床治疗进展[J].国际泌尿系统杂志,2016,0(3):447-452. 被引量:1